| | | Single nucleotide variant (missense variant +1 more) | Accelerated tumor formation, susceptibility to | |
| | | Single nucleotide variant (intron variant) | Accelerated tumor formation, susceptibility to | |
| | | Deletion (intron variant) | Accelerated tumor formation, susceptibility to | |
| | | Single nucleotide variant (intron variant) | Accelerated tumor formation, susceptibility to | |
| | | Deletion (frameshift variant) | Accelerated tumor formation, susceptibility to | |
| | | Single nucleotide variant (missense variant +1 more) | Accelerated tumor formation, susceptibility to | |
| | | Single nucleotide variant (intron variant) | Accelerated tumor formation, susceptibility to | |
| | | Single nucleotide variant (missense variant +1 more) | Accelerated tumor formation, susceptibility to | |
| | LOC126861563, MDM2 (D17G +1 more) | Single nucleotide variant (missense variant) | Accelerated tumor formation, susceptibility to | |
| | | Single nucleotide variant (synonymous variant) | Accelerated tumor formation, susceptibility to | |
| | | Single nucleotide variant (synonymous variant) | Accelerated tumor formation, susceptibility to | |
| | | Single nucleotide variant (missense variant +1 more) | Accelerated tumor formation, susceptibility to | |
| | | Single nucleotide variant (synonymous variant +1 more) | Accelerated tumor formation, susceptibility to | |
| | | Single nucleotide variant (missense variant) | Accelerated tumor formation, susceptibility to | |
| | | Single nucleotide variant (intron variant) | Accelerated tumor formation, susceptibility to | |
| | | Single nucleotide variant (missense variant +1 more) | Accelerated tumor formation, susceptibility to | |
| | | Single nucleotide variant (intron variant) | Accelerated tumor formation, susceptibility to | |
| | | Single nucleotide variant (splice acceptor variant +1 more) | Accelerated tumor formation, susceptibility to | |
| | | Single nucleotide variant (intron variant) | Accelerated tumor formation, susceptibility to | |
| | LOC126861563, MDM2 (A13V +1 more) | Single nucleotide variant (missense variant) | not specified +1 more | |
| | | Single nucleotide variant (missense variant) | Accelerated tumor formation, susceptibility to | |
| | | Single nucleotide variant (synonymous variant +1 more) | Accelerated tumor formation, susceptibility to | |
| | | Single nucleotide variant (synonymous variant +1 more) | Accelerated tumor formation, susceptibility to | |
| | | Single nucleotide variant (synonymous variant +1 more) | Accelerated tumor formation, susceptibility to | |
| | | Single nucleotide variant (missense variant) | Accelerated tumor formation, susceptibility to | |
| | | Single nucleotide variant (synonymous variant) | Accelerated tumor formation, susceptibility to | |
| | | Single nucleotide variant (synonymous variant) | Accelerated tumor formation, susceptibility to | |
| | | Single nucleotide variant (missense variant) | Accelerated tumor formation, susceptibility to | |
| | | Single nucleotide variant (missense variant) | Accelerated tumor formation, susceptibility to | |
| | | Single nucleotide variant (missense variant +1 more) | Accelerated tumor formation, susceptibility to | |
| | | Single nucleotide variant (intron variant) | Accelerated tumor formation, susceptibility to | |
| | | Single nucleotide variant (intron variant) | Accelerated tumor formation, susceptibility to | |
| | | Single nucleotide variant (missense variant) | Accelerated tumor formation, susceptibility to | |
| | | Single nucleotide variant (synonymous variant +1 more) | Accelerated tumor formation, susceptibility to | |
| | | Single nucleotide variant (synonymous variant +1 more) | Accelerated tumor formation, susceptibility to | |
| | | Single nucleotide variant (missense variant) | Accelerated tumor formation, susceptibility to | |
| | | Single nucleotide variant (missense variant) | Accelerated tumor formation, susceptibility to +1 more | |
| | | Single nucleotide variant (missense variant +1 more) | Accelerated tumor formation, susceptibility to | |
| | | Single nucleotide variant (missense variant) | Accelerated tumor formation, susceptibility to | |
| | | Single nucleotide variant (missense variant +1 more) | Accelerated tumor formation, susceptibility to | |
| | | Single nucleotide variant (intron variant) | Accelerated tumor formation, susceptibility to | |
| | | Single nucleotide variant (missense variant) | Accelerated tumor formation, susceptibility to | |
| | | Single nucleotide variant (synonymous variant +1 more) | Accelerated tumor formation, susceptibility to | |
| | | Single nucleotide variant (missense variant +1 more) | Accelerated tumor formation, susceptibility to +1 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant +1 more) | Accelerated tumor formation, susceptibility to | |
| | | Single nucleotide variant (synonymous variant +1 more) | Accelerated tumor formation, susceptibility to | |
| | | Single nucleotide variant (synonymous variant) | Accelerated tumor formation, susceptibility to | |
| | | Single nucleotide variant (intron variant) | Accelerated tumor formation, susceptibility to | |
| | | Single nucleotide variant (missense variant) | Accelerated tumor formation, susceptibility to | |
| | | Single nucleotide variant (intron variant) | Accelerated tumor formation, susceptibility to | |
| | LOC126861563, MDM2 (Q30K +1 more) | Single nucleotide variant (missense variant) | Accelerated tumor formation, susceptibility to | |
| | | Single nucleotide variant (missense variant +1 more) | Accelerated tumor formation, susceptibility to | |
| | | Single nucleotide variant (synonymous variant) | Accelerated tumor formation, susceptibility to | |
| | | Single nucleotide variant (missense variant +1 more) | Accelerated tumor formation, susceptibility to | |
| | | Single nucleotide variant (synonymous variant +1 more) | Accelerated tumor formation, susceptibility to | |
| | | Single nucleotide variant (missense variant) | Accelerated tumor formation, susceptibility to | |
| | | Single nucleotide variant (missense variant +1 more) | Accelerated tumor formation, susceptibility to | |
| | | Duplication (intron variant) | Accelerated tumor formation, susceptibility to | |
| | | Single nucleotide variant (intron variant) | Accelerated tumor formation, susceptibility to | |
| | | Single nucleotide variant (missense variant) | Accelerated tumor formation, susceptibility to | |
| | | Microsatellite (intron variant) | Accelerated tumor formation, susceptibility to | |
| | | Single nucleotide variant (missense variant +1 more) | Accelerated tumor formation, susceptibility to | |
| | | Single nucleotide variant (intron variant) | Accelerated tumor formation, susceptibility to | |
| | | Single nucleotide variant (intron variant) | Accelerated tumor formation, susceptibility to | |
| | | Single nucleotide variant (intron variant) | Accelerated tumor formation, susceptibility to | |
| | | Single nucleotide variant (missense variant) | Accelerated tumor formation, susceptibility to | |
| | | Single nucleotide variant (missense variant) | Accelerated tumor formation, susceptibility to | |
| | | Single nucleotide variant (intron variant) | Accelerated tumor formation, susceptibility to | |
| | | Deletion (intron variant) | Accelerated tumor formation, susceptibility to | |
| | | Single nucleotide variant (missense variant) | Accelerated tumor formation, susceptibility to | |
| | | Single nucleotide variant (missense variant +1 more) | Accelerated tumor formation, susceptibility to | |
| | | Single nucleotide variant (missense variant) | Accelerated tumor formation, susceptibility to | |
| | | Single nucleotide variant (missense variant +1 more) | Accelerated tumor formation, susceptibility to | |
| | | Single nucleotide variant (intron variant) | Accelerated tumor formation, susceptibility to | |
| | | Single nucleotide variant (intron variant) | Accelerated tumor formation, susceptibility to | |
| | | Single nucleotide variant (synonymous variant +1 more) | Accelerated tumor formation, susceptibility to | |
| | | Deletion (intron variant) | Accelerated tumor formation, susceptibility to | |
| | | Deletion (intron variant) | Accelerated tumor formation, susceptibility to | |
| | | Duplication (intron variant) | Accelerated tumor formation, susceptibility to | |
| | | Deletion (intron variant) | Accelerated tumor formation, susceptibility to | |
| | | Single nucleotide variant (synonymous variant) | Accelerated tumor formation, susceptibility to | |
| | | Single nucleotide variant (synonymous variant +1 more) | Accelerated tumor formation, susceptibility to | |
| | | Single nucleotide variant (intron variant) | Accelerated tumor formation, susceptibility to | |
| | | Single nucleotide variant (intron variant) | Accelerated tumor formation, susceptibility to | |
| | | Single nucleotide variant (intron variant) | Accelerated tumor formation, susceptibility to | |
| | | Single nucleotide variant (synonymous variant +1 more) | Accelerated tumor formation, susceptibility to | |
| | | Single nucleotide variant (synonymous variant) | Accelerated tumor formation, susceptibility to | |
| | | Single nucleotide variant (intron variant) | Accelerated tumor formation, susceptibility to | |
| | | Single nucleotide variant (intron variant) | Accelerated tumor formation, susceptibility to | |
| | | Single nucleotide variant (synonymous variant) | Accelerated tumor formation, susceptibility to +1 more | |
| | | Deletion (intron variant) | Accelerated tumor formation, susceptibility to | |
| | | Single nucleotide variant (intron variant) | Accelerated tumor formation, susceptibility to | |
| | LOC126861563, MDM2 (T10A +1 more) | Single nucleotide variant (missense variant) | Accelerated tumor formation, susceptibility to | |
| | | Single nucleotide variant (missense variant) | Accelerated tumor formation, susceptibility to | |
| | | Single nucleotide variant (missense variant +1 more) | Accelerated tumor formation, susceptibility to | |
| | | Single nucleotide variant (missense variant +1 more) | Accelerated tumor formation, susceptibility to | |
| | | Single nucleotide variant (missense variant +1 more) | Accelerated tumor formation, susceptibility to | |
| | | Single nucleotide variant (missense variant +1 more) | Accelerated tumor formation, susceptibility to | |
| | | Single nucleotide variant (missense variant +1 more) | Accelerated tumor formation, susceptibility to | |
| | | Single nucleotide variant (missense variant) | Accelerated tumor formation, susceptibility to | |